American Century Companies’s Nuvation Bio NUVB Stock Holding History

American Century Companies's NUVB Position: Q1 2026 in Review

American Century Companies increased its Nuvation Bio (NUVB) stake by 7,769% in Q1 2026, buying an estimated $15.9M and bringing the position to 2,897,078 shares worth $12.4M. The position accounts for 0.01% of the portfolio, ranked #1380.

American Century Companies first reported a position in NUVB in Q2 2022 and has held it in 15 quarters since. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

• American Century Companies held 2,897,078 shares of Nuvation Bio worth $12.4M as of Q1 2026.
• American Century Companies bought 2,860,262 Nuvation Bio shares in Q1 2026, an estimated $15.9M.
• Nuvation Bio made up 0.01% of American Century Companies's portfolio in Q1 2026, its #1380 holding.
• American Century Companies first reported a position in Nuvation Bio in Q2 2022 and has held it in 15 quarters since.
• 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.